Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angong Niuhuang Pill and Music Electroacupuncture for Post-Stroke Cognitive Impairment
NCT05731310Phase 1Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Aug 2022
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Angong Niuhuang Pill in post-stroke cognitive impairment (PSCI) (3 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Simple intelligence state examination scale at 4 weeks. Status: unknown.
02
Drugs
Angong Niuhuang Pill
03
Conditions
post-stroke cognitive impairment (PSCI)
Beyond the preview
Go deeper on NCT05731310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05731310.